CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE, the worldwide leader in using genetic and proteomic knowledge to enable patients, clinicians and pharmaceutical partners to identify and…

Collaboration Builds on Genetic Identification of Patients with Sjögren-Larsson Syndrome (SLS) in a Worldwide Cohort Enabling SLS Patients to Benefit…

Dr. Arndt Rolfs talks at ECRD about speeding up the rare disease knowledge and information eco-system based on proteomic screening tools

CENTOGENE’s Deep Expertise in Biomarker Identification to Help Guide Clinical Trials

CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and enable patients,…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

CENTOGENE highlights solutions for early diagnosis of rare hereditary disorders at the 2nd Annual Recent Advances in Rare Disease Conference.

CENTOGE…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, announced the publication…

CENTOGENE, the worldwide leader in elucidating rare disease genetics for patients, clinicians and pharmaceutical partners, today announced the…

CENTOGENE´s Chief Financial Officer, Richard Stoffelen, is scheduled to present at the upcoming Cowen and Company 38th Annual Health Care Conference…

For Further Inquiries Please Contact

Press Contact

Ben Legg

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads